1. World Health Organization. (2010) Medicines: spurious/falsely-labelled/falsified/counterfeit (SFFC) medicines. Fact sheet N°275. (January) World Health Organization, Geneva,
http://www.who.int/mediacentre/factsheets/fs275/en/index.html
, accessed 23 March 2012.
2. Caudron, J.M., Ford, N., Henkens, M., Mace, C., Kiddell-Monroe, R. and Pinel, J. (2008) Substandard medicines in resource-poor settings: A problem that can no longer be ignored. Tropical Medicine and International Health 13 (8): 1062–1072.
3. WHO. (2011) Report of the Working Group of Member States on Substandard/Spurious/Falsely-labeled/Falsified/Counterfeit Medical Products. 24 March,
http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_16-en.pdf
, accessed 30 July 2012.
4. Time to focus on quality. (February 2011) MSF Briefing Note ahead of the February 2011 meeting of the Working Group of WHO Member States on Substandard/spurious/falsely-labelled/falsified/counterfeit medical products. Médecins Sans Frontières,
http://www.msfaccess.org/content/briefing-note-time-focus-quality
, accessed 24 September 2012.
5. Park, C.S. (2009) Legal Aspects of Defining ‘Counterfeit Medicines’: A Discussion Paper. New Delhi: World Health Organization, Regional Office for South East Asia.